Tags

Results for Translational biology, medicine, and health graduate program

Rss Feed

- - Virginia Tech graduate students selected to join competitive Society for Neuroscience program
    Amnah Eltahir and Alyssa Brunal-Brown, Virginia Tech graduate students at the Fralin Biomedical Research Institute at VTC, were accepted into the Society for Neuroscience’s fellowship and associate programs, respectively.
- - Lost in translation: The medium is the message for a healthy heartbeat
    Researchers at the Fralin Biomedical Research Institute at VTC have revealed how a genetic message to produce healthy heart tissue is altered in the body during stress and aging to contribute to sudden cardiac death.
- - Madelynn Todd, Ryan King to represent students on Board of Visitors
    The two students will begin their one-year terms on July 1.
- - Virginia Tech Board of Visitors sets tuition and fees, advances new Ph.D. program in neuroscience
    During its quarterly meeting March 31-April 1, the board also approved the demolition of Holden Hall's north wing, selected student representatives for the coming year, and adopted resolutions for multiple faculty appointments and emerita/emeritus status.
- - Economist, UN advisor Jeffrey Sachs to discuss world’s 'most important agenda'
    Sachs will give his presentation "Achieving Sustainable Development in the United States and throughout the World" at 5:30 p.m. Feb. 21 at 2 Riverside Circle in Roanoke. The event will be free and open to the public.
- - VTCRI scientists find that sensory neurons can be used to discover therapies for ALS
    Virginia Tech Carilion Research Institute (VTCRI) scientists examined sensory neurons in cell cultures and in mice with ALS-causing mutant genes. They found that sensory neurons’ axons exhibit similar pathological changes found in motor neurons afflicted with ALS.
- - Roanoke-based Virginia Tech graduate student selected as a Society for Neuroscience fellow
    Ubadah Sabbagh is a doctoral student in Virginia Tech's Translational Biology, Medicine, and Health Graduate Program.
- - Veterinary college researcher awarded grant to study herpes simplex virus
    The National Institute of Neurological Disorders and Stroke of the National Institutes of Health has awarded Andrea Bertke, an assistant professor of infectious diseases in the Virginia-Maryland College of Veterinary Medicine, $1.7 million to study the neuron-specific regulation of herpes simplex viruses 1 and 2.
- - VTCRI scientist earns third concurrent grant from the National Cancer Institute to study breast cancer
    Deb Kelly, who is also an associate professor of biological sciences in the College of Science at Virginia Tech, is working to better detect, prevent, and repair the mutations found in cancers related to the breast cancer susceptibility protein, BRCA1.
- - VTCRI scientist awarded $2 million grant to study immune memory response
    The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded a new five-year grant to Ken Oestreich, an assistant professor at the Virginia Tech Carilion Research Institute, to study immunological memory.
- - VTCRI scientists, Carilion clinicians first to identify perinexus in human heart
    The research team was led by Steven Poelzing, an associate professor at the Virginia Tech Carilion Research Institute, and Soufian AlMahameed, who was a clinician associate professor at the Virginia Tech Carilion School of Medicine and the director of Carilion Clinic’s Center for Atrial Fibrillation at the time of data collection.
- - VTCRI scientists identify novel cellular mechanism that can lead to cancer metastasis
    Scientists at the Virginia Tech Carilion Research Institute have added a new dimension to the understanding of how cells alter their communication with one another during development, wound healing, and the spread of cancer.
- - National expert on the behavioral science of scarcity to speak at VTCRI
    Eldar Shafir will discuss the complex psychology of poverty and the tradeoffs people must make when resources are scarce on May 17 at the Virginia Tech Carilion Research Institute.
- - First students earn degrees through innovative translational biology, medicine, and health program
    The program is based on the Virginia Tech Carilion Health Sciences and Technology Campus in Roanoke, and it positions students to conduct research in more than 50 departments and institutes across Virginia Tech.
- - Compounds found in grapes, dark chocolate, coffee, and blueberries can be used to treat depression
    The finding — from a study published by a Virginia Tech researcher — does not mean that people who suffer from depression should eat a bar of dark chocolate or drink a bottle of red wine as self-treatment.
- - President of nation’s largest health and science public education and advocacy organization to speak at VTCRI
    Mary Woolley, president and chief executive officer of Research!America, will speak at the Virginia Tech Carilion Research Institute on April 5.
- - VTCRI scientist awarded $2 million National Cancer Institute grant to study breast cancer
    The National Cancer Institute of the National Institutes of Health has awarded Deborah Kelly, an associate professor at the Virginia Tech Carilion Research Institute, $2 million to study the mutated form of the breast cancer susceptibility protein that is implicated in hereditary breast cancer.
- - Scientists gain insight into the earliest changes that impair motor function during aging
    A team of biomedical scientists has found that motor neurons responsible for controlling muscle movement do not age. Rather, it's the synaptic inputs connected to the motor neurons that age and cause bodily decay.
- - National expert on cognitive control to deliver VTCRI Distinguished Public Lecture
    Jonathan Cohen, co-director of the Princeton Neuroscience Institute at Princeton University, will discuss the limitations of human focus during his presentation, “On the Rational Boundedness of Cognitive Control,” at 5:30 p.m. on March 22 at the Virginia Tech Carilion Research Institute.
- - Researchers discover molecular mechanism of hereditary, tumor-causing disease
    Von Hippel-Lindau syndrome is a rare disease, affecting about one in every 36,000 people, according to the National Institutes of Health. People with the disorder have an increased risk for developing cancer, but a main concern is on the syndrome’s characteristic benign growths.

Page 1 of 4 | 65 Results